Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
09/2010
09/09/2010US20100227892 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases
09/09/2010US20100227863 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds
09/09/2010US20100227811 Farnesylamine derivatives and methods of use
09/09/2010US20100224867 Electronic devices comprising structured organic films
09/08/2010EP2225204A1 Carbazole derivative, and light-emitting element, light-emitting device, and electronic device using carbazole derivative
09/08/2010EP2225203A1 Dehydrohalogenation process for the preparation of intermediates useful in providing 6,6-dimethyl-3-azabicyclo-[3.1.0]-hexane compounds
09/08/2010EP2225202A2 Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
09/08/2010EP2224922A2 Use of phthalimide and/or sulphonamide derivatives in the treatment of diseases which require reducing the tnf- levels and an exogenous source of nitric oxide, phthalimide derivatives, sulphonamide derivatives, and a method for obtaining a sulphonamide derivative
09/08/2010EP1915357B1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor
09/08/2010EP1763512B1 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers
09/08/2010CN1763006B Benzcarbazole compound and organic electroluminescent equipment thereof
09/08/2010CN101827814A Novel carbamoylglycine derivatives
09/08/2010CN101823993A Preparation method of L-octohydroindoline-2-formic acid
09/08/2010CN101823992A Preparation method of 4-nitroindole
09/08/2010CN101823965A Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
09/08/2010CN101822984A Catalyst for synthetizing indole and preparation method thereof
09/08/2010CN101016261B Preparing method of 4-phthalimidephenol
09/07/2010US7790906 indocyanine green; separating by-products (sodium iodide) via extraction
09/07/2010US7790902 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
09/07/2010US7790893 incorporating indolium ring moiety substituted at 3-position improves spectral properties; for detection of ligands; hybridization probes
09/07/2010US7790892 Aromatic compound and organic electroluminescent element containing the same
09/07/2010US7790754 such as (2R) N-((1R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl}ethyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide, useful in the treatment or prevention of symptoms such as pain and inflammation; analgesics and antiinflammatory agents
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
09/07/2010US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics
09/07/2010US7790394 Methods of analyzing a biological sample
09/07/2010US7790144 Receptor-avid exogenous optical contrast and therapeutic agents
09/02/2010WO2010098193A1 β-AMINOCARBONYL COMPOUND MANUFACTURING METHOD AND LITHIUM BINAPHTHOLATE COMPLEXES
09/02/2010WO2010097433A1 Quinone compounds as dopants in organic electronics
09/02/2010WO2010097374A1 Compounds for use as bradykinin b1 antagonists
09/02/2010US20100222381 Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100221764 Novel nitroreductase enzymatic substrates
09/02/2010US20100221662 Heat-sensitive imaging element
09/01/2010EP2224510A1 Organic electroluminescent device
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2223910A1 Oxime esters and photopolymerization initiators containing the same
09/01/2010EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2222308A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
09/01/2010EP2222287A2 Multitarget compounds active at a ppar and cannabinoid receptor
09/01/2010EP2222160A2 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
09/01/2010EP1921063B1 Indole compound, optical filter and optical recording material
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010EP1285651B1 Melanin concentrating hormone antagonists
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN1948298B Dopamine D3 acceptor portion agonist and its application
09/01/2010CN1938018B Use of compounds for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level
09/01/2010CN101821671A Liquid crystal aligning agent, method for producing liquid crystal alignment film, and liquid crystal display device
09/01/2010CN101821235A Pyrrolidin-2 -one derivatives as androgen receptor modulator
09/01/2010CN101821226A Leukotriene b4 inhibitors
09/01/2010CN101817778A Method for preparing indirubin from indigowoad leaves
09/01/2010CN101817773A Preparation method of chiral alpha-non-natural amino acid
09/01/2010CN101816649A Preparation method of 2,3-indolediketone-3-oxime and application in prevention and control of cancer
09/01/2010CN101537373B Axial chiral binaphthyl-containing spirocyclic phosphonium salt phase transfer catalyst and preparation method thereof
09/01/2010CN101323586B Synthetic process of L-5-hydroxy beta-indole alanine
09/01/2010CN101302185B Preparation of trandolaprilat
08/2010
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786162 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
08/31/2010US7786156 reacting [2-(5-Hydrazinomethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine with a 1,2,4-triazolyl forming reagent such as 1,3,5-triazine, formamidine, formamidinium salts or formamide, to obtain (3-[2-(dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole)
08/31/2010US7786146 such as N-[1-(4-Trifluoromethylbenzyl)-4,6-dimethylindoline-5-yl]-3,3-dimethyl-butyramide, used as antiepileptic agents
08/31/2010US7786142 1-(9H-carbazol-4-yloxy)propan-2-ol derivatives such as 1-(9H-carbazol-4-yloxy)-3-[(2,4-dimethoxybenzyl)-amino]propan-2-ol, used as phosphorylated signal transducers and activators of transcription (pSTAT3) and B-cell difeerentiation factor antagonists, for treating inflammatory diseases and cancer
08/31/2010US7786129 Piperazine derivatives of dialkyl oxindoles
08/31/2010US7786128 6-[4-(butane-1-sulfonyl)-piperazin-1-yl]-2-phenoxymethyl-1-(4-trifluoromethoxy-benzyl)-1H-benzoimidazole; cannabinoid receptors antagonists/inverse agonists; neuroleptic, antidepressant, anxiolytic agent, cognition activator, drug addiction
08/31/2010US7786119 Drug conjugates of ion channel modulating compounds
08/31/2010CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/31/2010CA2447779C Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
08/26/2010WO2010095621A1 Aromatic amine derivative and organic electroluminescent element
08/26/2010WO2010094289A1 Allosteric binding compounds
08/26/2010WO2010094242A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
08/26/2010US20100217013 Enantioselective process for the preparation of zolmitriptan
08/26/2010US20100216861 Amino arylsulfonamide compounds and their use as 5-ht6 ligands
08/26/2010US20100216840 Benzimidazolidinone derivatives as muscarinic agents
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives
08/26/2010US20100216803 Ornithine derivative
08/26/2010US20100216762 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof
08/26/2010US20100216746 Chemical compounds
08/26/2010US20100215710 Beta-2 Adrenergic Receptor Agonists and Antagonists and Modulation of Wound Healing
08/26/2010US20100215585 Dyes and precursors and conjugates thereof
08/25/2010EP2221347A1 Sulfonated diarylrhodamine dyes
08/25/2010EP2221296A1 Fused indane compound
08/25/2010EP2220041A1 Synthesis of quaternary salt compounds
08/25/2010EP1910338B1 Heterotetracyclic compounds as tpo mimetics
08/25/2010EP1742912B1 Novel androgens
08/25/2010EP1042286B1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
08/25/2010CN101815698A Degradation accelerator for polymers and polymer article comprising it
08/25/2010CN101812013A 8-oxy-8H-acenaphtho[1,2-b]pyrrole derivative and application thereof
08/25/2010CN101812012A Method for preparing o-phthaloyl threonine
08/25/2010CN101812011A Method for preparing o-phthaloyl serine
08/25/2010CN101812010A Isoindolinylcarboxylic ester derivative and preparation method
08/25/2010CN101812009A Novel technique for extracting L-tryptophan from fermentation broth
08/25/2010CN101811929A Method for concentrating and separating low-level anthracene and carbazole in residue after extraction of anthracene and carbazole
08/25/2010CN101323585B Enrichment and purification method of benzene acryloyl 5-hydroxytryptamine compound in safflower seed
08/25/2010CN101168526B 9-ethyl-3-carbazolmethylene-carbazolhydrazone and application thereof in detecting content of nitrite ion in solution
08/24/2010US7781628 in which an organic thin film layer comprising a single layer or plural layers including at least a light emitting layer is sandwiched between a cathode and an anode; high luminous efficiency
08/24/2010US7781599 economical; nontoxic; high yield; industrial scale; Grignard reaction; iron catalyst (FeCl3) and a diamine (ethylenediamine); cross-coupling of alkyl halide and aromatic organometallic; primary or secondary alkyl substituents; phenylcycloheptane from bromocycloheptane and phenyl magnesium bromide
08/24/2010US7781598 [4-Acetylamino-3-(4-chlorophenylsulfanyl)-2-methyl-1H-indol-1-yl]acetic acid; cleavage of dichloroDIPHENYL DISULFIDE to form the p-chloro thioether; reduction of nitro group; respiratory diseases
08/24/2010US7781480 Serine, threonine kinase inhibitor ; apoptosis in animal cells; anticancer agents; cardiovascular disorders; rheumatic disorders; skin disorders; vision defects; urogenital disorders; central nervous system disorders; infections
08/24/2010US7781479 Antidiabetic agents; controlling blood sugar; stimulate peroxisome proliferator activator receptor
08/24/2010US7781478 treatment of viral diseases or affecting viral internal ribosome entry site (IRES) activity, comprisng administering 3-nitilo-indole derivatives
08/24/2010US7781477 Therapeutic use of N-(1H-Indolyl)-1H-indole-2-carboxamide derivatives
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 458